Vitalhub Corp.
TSX:VHI.TOMedical - Healthcare Information Services
+$0.04 today
- Market cap
- $421.84M
- Beta
- 0.77
- P/E (TTM)
- 62.1
- EPS (TTM)
- $0.12
Volume 0.23M
Average 0.41M
VHI.TO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Vitalhub Corp.TSX: VHI.TO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development grows, but more slowly than its trailing trend
Q1 FY2026 research & development of CA$9.04M rose 73.1% year over year, behind the +92.4% change in trailing-twelve-month research & development. Sequentially, it rose 6.8% from the prior quarter. Over 3 fiscal years it compounded at +40.5% a year.
Context
- Research & development amounted to 26.6% of revenue in FY2025, up 4.4 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +73.1% toward the trailing-twelve-month pace of +92.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CAD · from the income statement
- Latest · FY2025
- 28.95M CAD
- Year-over-year change
- +90.1%
- 4-year CAGR
- +47.9%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 28.95M | +90.1% |
| FY2024 | 2024-12-31 | 15.23M | +25.1% |
| FY2023 | 2023-12-31 | 12.17M | +16.7% |
| FY2022 | 2022-12-31 | 10.43M | +72.5% |
| FY2021 | 2021-12-31 | 6.05M | — |
Research & Development vs competitors
How VHI.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +92.4% is the highest of 6, against a peer median of -25.6%.
- Research & development amounts to 27.5% of revenue for VHI.TO, versus a peer median of 4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$33.61M CAD | +45.4% | +25.2% | 6.6% | |
| LTM Mar 2026 | CA$32.77M CAD | +92.4% | +40.5% | 27.5% | |
| LTM Mar 2026 | CA$13.33M CAD | -25.6% | -7.0% | 20.0% | |
| LTM Mar 2026 | CA$4.85M CAD | +31.9% | -15.1% | 1.5% | |
| LTM Mar 2026 | CA$1.84M CAD | -59.9% | — | 66.7% | |
| LTM Mar 2026 | $0 USD | -100.0% | -39.8% | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding VHI.TO) | — | -25.6% | -11.0% | 4.1% | |
Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 24.66M | 39.97M | 52.51M | 68.59M | 108.97M |
| Cost of Revenue | 5.24M | 7.03M | 9.7M | 13.1M | 32.46M |
| Gross Profit | 19.43M | 32.94M | 42.81M | 55.49M | 76.51M |
| Gross Margin | 78.8% | 82.4% | 81.5% | 80.9% | 70.2% |
| Research & Development | 6.05M | 10.43M | 12.17M | 15.23M | 28.95M |
| Selling, General & Admin | 10.41M | 13.97M | 18.8M | 24.56M | 35.39M |
| Operating Expenses | 19.13M | 28.28M | 42.81M | 45.75M | 64.34M |
| Depreciation & Amortization | 2.68M | 3.87M | 4.98M | 5.96M | 11.08M |
| EBITDA | 1.12M | 5.25M | 10.38M | 11.9M | 23.25M |
| EBITDA Margin | 4.5% | 13.1% | 19.8% | 17.4% | 21.3% |
| Operating Income | 324.33K | 4.66M | 6.86M | 9.74M | 12.17M |
| Operating Margin | 1.3% | 11.7% | 13.1% | 14.2% | 11.2% |
| Interest Income | 29.55K | 0 | 489.57K | 1.95M | 2.42M |
| Interest Expense | 82.43K | 70.35K | 71.98K | 43.01K | 70.35K |
| Other Income / Expenses | (1.94M) | (6.28M) | (1.53M) | (3.85M) | (6.27M) |
| Income Before Tax | (1.61M) | 1.31M | 5.33M | 5.9M | 5.9M |
| Pre-Tax Margin | -6.5% | 3.3% | 10.1% | 8.6% | 5.4% |
| Income Tax Expense | 333.08K | 92.08K | 778.25K | 2.9M | (209.56K) |
| Net Income | (1.95M) | 1.21M | 4.55M | 3M | 6.11M |
| Net Margin | -7.9% | 3.0% | 8.7% | 4.4% | 5.6% |
| EPS (Basic) | (0.05) | 0.03 | 0.10 | 0.06 | 0.10 |
| EPS (Diluted) | (0.05) | 0.03 | 0.10 | 0.06 | 0.10 |
| Weighted Avg Shares | 36.4M | 41.49M | 43.65M | 49.2M | 58.54M |
| Weighted Avg Shares (Diluted) | 36.4M | 42.56M | 46.6M | 50.93M | 60.29M |
Vitalhub Corp.
TSX:VHI.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.